Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity
Clinical trial NCT05579977 · TERMINATED
Trial details
- NCT number
- NCT05579977
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-27
- Primary completion
- 2023-07-14
- Enrollment
- 902
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.